| Primary |
| Chronic Obstructive Pulmonary Disease |
23.1% |
| Glioblastoma Multiforme |
15.4% |
| Blood Creatinine Increased |
7.7% |
| Breast Cancer |
7.7% |
| Chronic Sinusitis |
7.7% |
| Lower Respiratory Tract Infection |
7.7% |
| Prophylaxis |
7.7% |
| Pulmonary Hypertension |
7.7% |
| Rhinitis |
7.7% |
| Subacute Endocarditis |
7.7% |
|
| Throat Irritation |
18.2% |
| Medication Error |
15.2% |
| Circumstance Or Information Capable Of Leading To Medication Error |
6.1% |
| Rash |
6.1% |
| Respiratory Fume Inhalation Disorder |
6.1% |
| Wrong Drug Administered |
6.1% |
| Accidental Exposure |
3.0% |
| Accidental Overdose |
3.0% |
| Agranulocytosis |
3.0% |
| Burning Sensation |
3.0% |
| Convulsion |
3.0% |
| Death |
3.0% |
| Drug Ineffective |
3.0% |
| Drug Interaction |
3.0% |
| Dyspnoea |
3.0% |
| Encephalopathy |
3.0% |
| Generalised Erythema |
3.0% |
| Heart Rate Increased |
3.0% |
| Hypersensitivity |
3.0% |
| Increased Bronchial Secretion |
3.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
43.6% |
| Product Used For Unknown Indication |
9.1% |
| Pharyngitis |
7.7% |
| Osteoporosis |
5.0% |
| Hypertension |
4.5% |
| Nasopharyngitis |
4.5% |
| Cough |
3.6% |
| Diabetes Mellitus |
3.6% |
| Glioblastoma Multiforme |
3.2% |
| Ill-defined Disorder |
2.7% |
| Chronic Sinusitis |
2.3% |
| Dyslipidaemia |
1.8% |
| Hyperphosphataemia |
1.4% |
| Renal Transplant |
1.4% |
| Atrial Fibrillation |
0.9% |
| Bronchiolitis |
0.9% |
| Deep Vein Thrombosis |
0.9% |
| Ear Infection |
0.9% |
| Influenza |
0.9% |
| Insomnia |
0.9% |
|
| Visual Disturbance |
16.9% |
| Intra-uterine Death |
13.6% |
| Stillbirth |
13.6% |
| Urticaria |
8.5% |
| Foetal Growth Restriction |
6.8% |
| Hallucination |
5.1% |
| Foetal Death |
3.4% |
| Maternal Exposure Timing Unspecified |
3.4% |
| Medication Error |
3.4% |
| Rhabdomyolysis |
3.4% |
| Skin Exfoliation |
3.4% |
| Toxic Skin Eruption |
3.4% |
| White Blood Cell Count Increased |
3.4% |
| Aplasia |
1.7% |
| Atrial Fibrillation |
1.7% |
| Circumstance Or Information Capable Of Leading To Medication Error |
1.7% |
| Dermatitis Exfoliative |
1.7% |
| Dialysis |
1.7% |
| Drug Exposure During Pregnancy |
1.7% |
| Erysipelas |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.5% |
| Drug Use For Unknown Indication |
17.4% |
| Pain |
6.4% |
| Coronary Artery Bypass |
5.2% |
| Prophylaxis |
5.0% |
| Nuclear Magnetic Resonance Imaging |
5.0% |
| Chronic Obstructive Pulmonary Disease |
4.2% |
| Hypertension |
4.1% |
| Chemotherapy |
3.1% |
| Angiogram |
3.0% |
| Nausea |
3.0% |
| Constipation |
3.0% |
| Insomnia |
2.8% |
| Multiple Myeloma |
2.1% |
| Depression |
1.9% |
| Asthma |
1.8% |
| Convulsion |
1.7% |
| Nuclear Magnetic Resonance Imaging Abdominal |
1.7% |
| Osteoporosis |
1.6% |
| Dyspnoea |
1.5% |
|
| Injury |
8.6% |
| Pain |
8.1% |
| Pneumonia |
7.5% |
| Fear |
7.0% |
| Renal Failure Acute |
5.9% |
| Cholestasis |
5.4% |
| Renal Failure |
5.4% |
| Emotional Distress |
4.8% |
| Vomiting |
4.8% |
| Walking Aid User |
4.8% |
| White Blood Cell Count Increased |
4.8% |
| Anhedonia |
4.3% |
| Unevaluable Event |
4.3% |
| Urticaria |
4.3% |
| Weight Increased |
4.3% |
| Weight Decreased |
3.8% |
| Fatigue |
3.2% |
| Skin Turgor Decreased |
3.2% |
| Anxiety |
2.7% |
| Dehydration |
2.7% |
|
